Chymase and matrix metalloproteinase

Hypertension Research

Volumn 30, Issue 1, 2007, Pages 3-4

  Urata, Hidenori ^a  

^a Fukuoka University Chikushi Hospital   (Japan)

Author keywords

Chymase; Chymase inhibitor; Matrix metalloproteinase; Neointimal proliferation

Indexed keywords

ANGIOTENSIN II; ANGIOTENSIN RECEPTOR ANTAGONIST; CHYMASE; CHYMASE INHIBITOR; GELATINASE A; MATRIX METALLOPROTEINASE; N [1 BENZYL 2,3 DIOXO 6 (2 PYRIDYLOXY)HEXYL] 2 (5 FORMYLAMINO 1,6 DIHYDRO 6 OXO 2 PHENYL 1 PYRIMIDINYL)ACETAMIDE;

ARTERY INJURY; ARTERY INTIMA PROLIFERATION; ATHEROSCLEROSIS; BLOOD VESSEL PERFORATION; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY OBSTRUCTION; DRUG ELUTING STENT; DRUG MECHANISM; EDITORIAL; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; HEART VENTRICLE HYPERTROPHY; HUMAN; NONHUMAN; PATHOPHYSIOLOGY; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; TRANSLUMINAL CORONARY ANGIOPLASTY;

ANIMALS; ARTERIES; BALLOON DILATATION; CHYMASES; HUMANS; HYPERPLASIA; MATRIX METALLOPROTEINASES; PROTEASE INHIBITORS;

EID: 33847029092     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1291/hypres.30.3     Document Type: Editorial

References (15)

1. Moses MA, Marikovsky M, Harper JW, et al: Temporal study of the activity of matrix metalloproteinases and their endogenous inhibitors during wound healing. J Cell Biochem 1996; 60: 379-386.
2. Liotta LA, Tryggvason K, Garbisa S, Hart I, Foltz CM, Shafie S: Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature 1980; 284: 67-68.
3. George SJ, Johnson JL, Angelini GD, Jeremy JY: Short-term exposure to thapsigargin inhibits neointima formation in human saphenous vein. Arterioscler Thromb Vasc Biol 1997; 17: 2500-2506.
4. Wang M, Takagi G, Asai K, et al: Aging increases aortic MMP-2 activity and angiotensin II in nonhuman primates. Hypertension 2003; 41: 1308-1316.
5. Suzuki K, Lees M, Newlands GF, Nagase H, Woolley DE: Activation of precursors for matrix metalloproteinases 1 (interstitial collagenase) and 3 (stromelysin) by rat mast-cell proteinases I and II. Biochem J 1995; 305: 301-306.
6. Fang KC, Raymond WW, Blount JL, Caughey GH: Dog mast cell alpha-chymase activates progelatinase B by cleaving the Phe88-Gln89 and Phe91-Glu92 bonds of the catalytic domain. J Biol Chem 1997; 272: 25628-25635.
7. Tchougounova E, Lundequist A, Fajardo I, Winberg JO, Ahrink M, Pejler G: A key role for mast cell chymase in the activation of pro-matrix metalloprotease-9 and pro-matrix metalloprotease-2. J Biol Chem 2005; 280: 9291-9296.
8. Chandrasekharan UM, Sanker S, Glynias MJ, Karnik SS, Husain A: Angiotensin II-forming activity in a reconstructed ancestral chymase. Science 1996; 271: 502-505.
9. Peters S, Gotting B, Trummel M, Rust H, Brattstrom A: Valsartan for prevention of restenosis after stenting of type B2/C lesions: the VAL-PREST trial. J Invasive Cardiol 2001; 13: 93-97.
10. MERCATOR Study Group: Does the new angiotensin converting enzyme inhibitor cilazapril prevent restenosis after percutaneous transluminal coronary angioplasty? Results of the MERCATOR study: a multicenter, randomized, double-blind placebo-controlled trial. Multicenter European Research Trial with Cilazapril after Angioplasty to Prevent Transluminal Coronary Obstruction and Restenosis (MERCATOR) Study Group. Circulation 1992; 86:100-110.
11. Takai S, Miyazaki M: A novel therapeutic strategy against vascular disorders with chymase inhibitor. Curr Vasc Pharmacol 2003; 1: 217-224.
12. Kishi K, Muramatsu M, Jin D, et al: The effects of chymase on matrix metalloproteinase-2 activation in neointimal hyperplasia after balloon injury in dogs. Hypertens Res 2007; 30: 77-83.
13. Ben-Gal Y, Moshkovitz Y, Nesher N, et al: Drug-eluting stents versus coronary artery bypass grafting in patients with diabetes mellitus. Ann Thorac Surg 2006; 82: 1692-1697.
14. Ihara M, Urata H, Kinoshita A, et al: Increased chymase-dependent angiotensin II formation in human atherosclerotic aorta. Hypertension 1999; 33: 1399-1405.
15. Uehara Y, Urata H, Ideishi M, Arakawa K, Saku K: Chymase inhibition suppresses high-cholesterol diet-induced lipid accumulation in the hamster aorta. Cardiovasc Res 2002; 55: 870-876.